Restrictive Versus Liberal Transfusion Strategies in Myelodysplastic Syndrome and Beyond.
Publication/Presentation Date
12-1-2019
Abstract
Anemia is the most common cytopenia seen in the myelodysplastic syndromes (MDS). The majority of patients with MDS will require red blood cell (RBC) transfusions during the course of their disease. However, unlike many other disease groups, there is no consensus on the optimal strategy for RBC transfusion in this patient population. In this article, we review the data supporting the use of restrictive transfusion strategies in multiple patient populations and discuss the current literature regarding transfusion management in patients with MDS.
Volume
19
Issue
12
First Page
758
Last Page
762
ISSN
2152-2669
Published In/Presented At
Wilde, L., & Pan, J. (2019). Restrictive Versus Liberal Transfusion Strategies in Myelodysplastic Syndrome and Beyond. Clinical lymphoma, myeloma & leukemia, 19(12), 758–762. https://doi.org/10.1016/j.clml.2019.10.001
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
31678078
Department(s)
Administration and Leadership
Document Type
Article